Taltz.com lookup results from whois.brandsight.com server:
- Domain created: 2011-11-18T15:47:48Z
- Domain updated: 2020-10-12T04:18:35Z
- Domain expires: 2021-11-18T15:47:48Z 0 Years, 191 Days left
- Website age: 9 Years, 174 Days
- Registrar Domain ID: 1687824322_DOMAIN_COM-VRSN
- Registrar Url: http://brandsight.com
- Registrar WHOIS Server: whois.brandsight.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +1 (518) 290-0169
- Name server:
DNS Records / DNS Lookup
|A||60||IP : 18.104.22.168
|A||60||IP : 22.214.171.124
|A||60||IP : 126.96.36.199
|A||60||IP : 188.8.131.52
|A||60||IP : 184.108.40.206
|A||60||IP : 220.127.116.11
|A||60||IP : 18.104.22.168
|A||60||IP : 22.214.171.124
|NS||86400||TARGET : udns2.cscdns.uk
|NS||86400||TARGET : udns1.cscdns.net
|SOA||86400||MNAME : udns1.cscdns.net
RNAME : hostmaster.cscdns.net
SERIAL : 2019101127
REFRESH : 28800
RETRY : 7200
EXPIRE : 1209600
MINIMUM-TTL : 86400
|TXT||300||TXT : F9C6-823E-43F2-A9F8-BA6E-6497-0116-B597
|TXT||300||TXT : facebook-domain-verification=7d7rxttb8v41pfu1zyu39c5lvyfyry
|Health Conditions and Concerns||20%|
Email address with taltz.com
See Web Sites Hosted on 126.96.36.199
We found at least 10 Websites Listing below when search with taltz.com on Search Engine
Dosing Schedule | Plaque Psoriasis | Taltz® (ixekizumab)
Www.taltz.com Learn about the recommended Taltz (ixekizumab) dosing schedule for patients with moderate to severe plaque psoriasis (PsO).
Treatment Efficacy | Rheumatology PsA | Taltz (ixekizumab)
Www.taltz.com Find information about the efficacy of Taltz (ixekizumab) for the treatment of active psoriatic arthritis (PsA). See data at weeks 24 and through week 156.
Healthcare Provider Updates | Taltz (ixekizumab)
Taltz vs Humira® (adalimumab) | Rheumatology PsA | Taltz ...
Www.taltz.com TALTZ vs HUMIRA ® (adalimumab) FOR BIOLOGIC NAIVE PATIENTS WITH PSORIATIC ARTHRITIS. The first and only IL-17A antagonist to demonstrate superiority in a head-to-head trial against Humira in PsA. 1-5. As measured by the percentage of patients who simultaneously achieved both ACR50 and PASI 100 at week 24. 1 PsA=psoriatic arthritis.
Taltz® (ixekizumab) Rheumatology Savings and Support ...
Www.taltz.com PP-RC-US-1402 04/2021 ©Lilly USA, LLC 2021. All rights reserved.
Mechanism of Action | IL-17A & IgG4 | Taltz (ixekizumab)
Www.taltz.com About Taltz Taltz is designed to specifically target interleukin-17A (IL-17A) 1-5 IL-17A has been implicated in the pathogenesis of psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis
Preparing an Appeal Letter - Taltz
Www.taltz.com 4. Reference: 1. Taltz [package insert]. Indianapolis, IN: Eli Lilly and Company; 2020. Taltz® is a registered trademark owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Taltz | CrmRegistrationForm
Www.taltz.com By clicking submit, you are certifying that you are at least 18 years of age, a U.S. resident, and you agree to disclose your personal information to Lilly and its agents, and to be contacted regarding products, services, sharing your story, and/or other information related to dermatology or rheumatology products.
Taltz® (ixekizumab) Dermatology Savings and Support ...
Www.taltz.com By signing below, I certify: 1) The therapy is medically necessary and that this information is accurate to the best of my knowledge; 2) I am disclosing this information to …
Www.taltz.com Redirecting to /hcp/getting-patients-started.
Composing a Letter of Medical Necessity - Taltz
Www.taltz.com 2 To whom it may concern: I am writing to provide additional information to support my claim for [patient’s name] ’s treatment of [diagnosis and ICD code] with Taltz (ixekizumab). In brief, treatment with Taltz [dose, frequency] is medically appropriate and necessary for this patient. This letter includes the patient’s medical history, previous treatments, disease severity, and a recent ...
Taltz Injection | Taking Taltz | Taltz® (ixekizumab)
Commercial Coverage for Patients | Support Resources ...
Www.taltz.com Field Reimbursement Support. The Field Reimbursement Manager is an experienced access professional who can help your patients navigate the complex access and reimbursement environment
Taltz TogetherTM | Taltz® (ixekizumab)
Drafting a Coverage Authorization Request Letter
Www.taltz.com 2 To whom it may concern: This letter serves as a coverage authorization request for Taltz (ixekizumab) for [patient’s name, plan identification number, and group number] for the treatment of [diagnosis and ICD code]. Patient’s history, diagnosis, condition, and symptoms*:
Taltz® (ixekizumab) Pediatric Savings and Support ...
Www.taltz.com PP-RC-US-1431 04/2021 ©Lilly USA, LLC 2021. All rights reserved.
Www.taltz.com Redirecting to /psoriatic-arthritis.
Biologic Injection Medication | PsO, PsA & axSpA | Taltz ...
Www.taltz.com Biologic Injection Medication | PsO, PsA & axSpA | Taltz ...
Safety Data | Dermatology | Taltz (ixekizumab)
Devices | Autoinjector & Prefilled Syringe | Taltz ...
C-IX-US-0086_IX-HCP-EFF-Visible Results by 12 weeks_LINE_v2
Www.taltz.com C-IX-US-0086_IX-HCP-EFF-Visible Results by 12 weeks_LINE_v2
C-IX-US-0293_IX-HCP-EFF-UNCOVER-3-PASI-WEEK-264_v2 ... - Taltz
Www.taltz.com C-IX-US-0293_IX-HCP-EFF-UNCOVER-3-PASI-WEEK-264_v2 ... - Taltz
C-IX-US-0620-IX-HCP-EFF-Visible results_v3 - Taltz
Www.taltz.com C-IX-US-0620-IX-HCP-EFF-Visible results_v3 - Taltz